Gland Pharma, which is majority owned by China’s Shanghai Fosun Pharmaceutical (Fosun Pharma), has received a crucial nod from market regulator Sebi to launch an initial public offering (IPO) to raise up to Rs 6,000 crore. The company was incorporated in 1978 based in Hyderabad. The company is a manufacturer, marketer, and developer of complex injectables across its seven manufacturing facilities.
Gland Pharma IPO will be India's largest pharma IPO in the history. The company is coming up with 1250 crore fresh issue and 5229 crores of offer for sale. The company was incorporated in 1978 based in Hyderabad. The company is a manufacturer, marketer, and developer of complex injectables across its seven manufacturing facilities. They are one of the largest and fastest-growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India, and other markets. They promoted by China-based Shanghai Fosun Pharma, a global pharmaceutical major. Check out Gland Pharma IPO dates, price band, and market lot details.
Read Also:
Gland Pharma IPO Review:
- Adding Soon
Gland Pharma IPO Dates & Price Band:
| IPO Open: | 09 November 2020. Monday |
| IPO Close: | 11 November 2020, Wednesday |
| Offer Size: | Fresh issue: Rs 1,250 crore; OFS: Rs 5194.6 crore to Rs 5229.5 crore |
| Face Value: | ₹ 1 Per Equity Share |
| Price Band: | ₹ 1490-1500 Per Share |
| Listing on: | NSE & BSE |
| Retail Portion: | 35 % |
| Equity: | 3.48 Crore Shares |
| Type of Issue | Fresh issue of equity shares aggregating to Rs. 1,250 crore and offer for sale of up to 3.48 crore equity shares |
| Lot Size: | Minimum 10 Shares & Maximum 130 Shares |
| Minimum Amount: | ₹15,000 |
| Maximum Amount: | ₹1,95,000 |
Category-wise Break up of Gland Pharma IPO
- Anchor: 1,29,59,090 Shares = 1,943.86 Crores
- QIB: 86,39,394 Shares = 1,295.91 Crores
- NII: 64,79,545 Shares = 971.93 Crores
- RII: 1,51,18,939 Shares = 2,267.84 Crores (Lot size:10 = 15,11,894 Forms)
- Total Issue: 4,31,96,968 Shares = 6,479.55 Crores.
Gland Pharma IPO financial performance (in INR Crore)
| ₹ in INR Crore | |||||
| Revenue | Expense | Income | |||
| 2017 | x | x | x | ||
| 2018 | 1672 | 1170 | 321 | ||
| 2019 | 2130 | 1424 | 452 | ||
| 2020 | 2772 | 1780 | 768 | ||
Gland Pharma IPO Allotment & Listing:
Basis of Allotment: | 17 November 2020 |
Refunds: | 18 November 2020 |
Credit to Demat Account: | 19 November 2020 |
Listing Date: | 20 November 2020 |
Gland Pharma IPO Form:
How to apply the Gland Pharma IPO? You can apply Gland Pharma IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Gland Pharma IPO in the Invest section. The other option you can apply Gland Pharma IPO via IPO forms download via NSE and BSE. Check out the Gland Pharma forms - click NSE Forms & BSE Forms blank IPO forms download, fill and submit in your bank or with your broker.About Gland Pharma Company:
Gland Pharma is a holistic objective of dispensing health through a portfolio of injectable products across various therapeutic segments and delivery systems, has helped gland pharma expand to seven manufacturing facilities in India, with a capacity of approximately 750 million units. These include four facilities with 22 production lines for finished formulations and three Active Pharmaceutical Ingredient (API) facilities. Gland Pharma products are produced at world-class manufacturing facilities and conform to global compliance, regulatory and quality specifications.
Gland Phara are present in sterile injectables, oncology and ophthalmic segments, and focus on complex injectables including NCE-1s, First-to-File products and 505(b)(2) filings. Our products are currently delivered via liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags and drops; and efforts are underway to augment additional manufacturing capabilities in complex injectables such as peptides, long-acting injectables, suspensions and hormonal products. We are also in the process of including new delivery systems such as pens and cartridges into company product portfolio.
Company Promoters:
- Fosun Pharma Industrial Pte. Ltd.
- Shanghai Fosun Pharmaceutical (Group) Co. Ltd.
Quick Links:
Gland Pharma IPO Registrar:
Link Intime India Private Ltd
C 101, 247 Park, L.B.S.Marg,
Vikhroli (West), Mumbai - 400083
Phone: +91-22-4918 6270
Email: glandpharma.ipo@linkintime.co.in
Website: http://www.linkintime.co.in
Note: Check Gland Pharma IPO allotment status on -website allotment URL. Click Here
Gland Pharma IPO Lead Managers:
- Citigroup Global Markets India Private Limited
- Haitong Securities India Private Limited
- Kotak Mahindra Capital Company Limited
- Nomura Financial Advisory And Securities (India) Pvt Ltd
Company Address:
Gland Pharma LimitedSurvey No. 143-148, 150 & 151Near Gandimaisamma 'X' RoadsD.P. Pally, Dundigal Gandimaisamma MandalMedchal-Malkajgiri DistrictHyderabad 500043, Telangana, India
Gland Pharma IPO FAQs:
When Gland Pharma IPO will open for Anchor Investors?
The Anchor Investors bidding is not announced yet.
When Gland Pharma IPO will open for QIB, NII, and Retail?
The IPO to open on 09 November for QIB, NII, and Retail Investors.
What is Gland Pharma IPO Investors Portion?
The investors' portion for QIB--50%, NII--15%, and Retail--35%.
How to Apply the Gland Pharma IPO?
You can apply Gland Pharma IPO via ASBA online via your bank account. You can apply ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form.
What is Gland Pharma IPO Allotment Date?
Gland Pharma IPO allotment date is November 2020. You can check IPO allotment here.
What is Gland Pharma IPO Listing Date?
Gland Pharma IPO listing date is November 2020. The IPO to list on NSE and BSE.
